ABBOTT LABS: Bid to Revoke Bayer’s Humera Patent Still Pending
Abbott Laboratories’ application to revoke Bayer HealthCare LLC’s Humira(R) patent remains pending.
In its 2009 annual report on Form 10-K, Abbott reported that litigation is pending in the Regional Court in…